• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

五个欧洲国家中影响更年期症状治疗决策的行为和态度。

Behaviours and attitudes influencing treatment decisions for menopausal symptoms in five European countries.

作者信息

Constantine Ginger D, Graham Shelli, Clerinx Cathy, Bernick Brian A, Krassan Mitchell, Mirkin Sebastian, Currie Heather

机构信息

EndoRheum Consultants LLC, Malvern, PA, USA

TherapeuticsMD, Boca Raton, FL, USA.

出版信息

Post Reprod Health. 2016 Sep;22(3):112-22. doi: 10.1177/2053369116632439. Epub 2016 Feb 18.

DOI:10.1177/2053369116632439
PMID:26895640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5019289/
Abstract

OBJECTIVE

To assess women's behaviours and attitudes regarding the treatment of menopausal symptoms in five European countries.

STUDY DESIGN

Women aged ≥45 years in France, Germany, Italy, Spain, and the United Kingdom participated in an internet survey. Completers were those who reported menopausal symptoms and had treated their symptoms. Women were equally stratified by age (45-54 years, 55-64 years, ≥65 years).

MAIN OUTCOME MEASURES

Behaviours, attitudes, and experiences regarding treatment of menopausal symptoms.

RESULTS

Of 3890 peri- to postmenopausal women screened, 67% experienced symptoms and 54% sought either medical input or some treatment concerning their symptoms. Hot flushes, the most common symptom, decreased with age but remained prevalent after age 64. Roughly 75% of women who sought relief consulted a physician, mostly a gynaecologist or a general practitioner (GP) as in the United Kingdom. The decision to seek treatment was influenced by age, number, and severity of symptoms. Approximately 79% visiting a physician received prescription therapy. Of the women who received non-hormone therapy (HT) treatment instead of HT: patients refused HT (20-44%), physicians did not discuss HT (32-46%), or advised against HT (24-43%). Women in the United Kingdom were most familiar with and favorable to HT. Interest in a new HT (34-50%) was higher than use (19-28%).

CONCLUSIONS

Menopausal symptoms are common, persistent, and bothersome, but many fail to seek treatment. Sources and types of treatment vary among age groups and countries. Education regarding women's attitudes toward treatment should be provided to those physicians who treat menopausal symptoms in each country.

摘要

目的

评估五个欧洲国家女性在更年期症状治疗方面的行为和态度。

研究设计

法国、德国、意大利、西班牙和英国年龄≥45岁的女性参与了一项网络调查。完成调查者为报告有更年期症状并对症状进行了治疗的女性。女性按年龄(45 - 54岁、55 - 64岁、≥65岁)进行了均衡分层。

主要观察指标

更年期症状治疗方面的行为、态度和经历。

结果

在3890名围绝经期至绝经后女性中,67%有症状,54%就其症状寻求了医疗建议或某种治疗。潮热是最常见的症状,随年龄增长而减少,但在64岁后仍很普遍。寻求缓解的女性中约75%咨询了医生,在英国,大多咨询妇科医生或全科医生(GP)。寻求治疗的决定受年龄、症状数量和严重程度影响。约79%看医生的女性接受了处方治疗。在接受非激素疗法(HT)而非HT治疗的女性中:患者拒绝HT(20 - 44%)、医生未讨论HT(32 - 46%)或建议不采用HT(24 - 43%)。英国女性对HT最熟悉且最支持。对新型HT的兴趣(34 - 50%)高于使用率(19 - 28%)。

结论

更年期症状常见、持续且令人烦恼,但许多人未寻求治疗。治疗来源和类型在不同年龄组和国家有所不同。应向各国治疗更年期症状的医生提供有关女性治疗态度的教育。

相似文献

1
Behaviours and attitudes influencing treatment decisions for menopausal symptoms in five European countries.五个欧洲国家中影响更年期症状治疗决策的行为和态度。
Post Reprod Health. 2016 Sep;22(3):112-22. doi: 10.1177/2053369116632439. Epub 2016 Feb 18.
2
Prevalence and opinions of hormone therapy prior to the Women's Health Initiative: a multinational survey on four continents.妇女健康倡议研究之前激素治疗的患病率及观点:一项在四大洲开展的多国调查
J Womens Health (Larchmt). 2008 Sep;17(7):1151-66. doi: 10.1089/jwh.2007.0584.
3
Women's perception of sexuality around the menopause: outcomes of a European telephone survey.女性对更年期前后性行为的认知:一项欧洲电话调查的结果
Eur J Obstet Gynecol Reprod Biol. 2008 Mar;137(1):10-6. doi: 10.1016/j.ejogrb.2006.10.036. Epub 2007 Jan 4.
4
The dilemma of menopause and hormone replacement--a challenge for women and health-care providers: knowledge of menopause and hormone therapy in Spanish menopausal women.更年期与激素替代疗法的困境——对女性和医疗保健提供者的挑战:西班牙更年期女性对更年期及激素疗法的认知
Climacteric. 2006 Oct;9(5):380-7. doi: 10.1080/13697130600955385.
5
Characteristics of post-menopausal women with genitourinary syndrome of menopause: Implications for vulvovaginal atrophy diagnosis and treatment selection.绝经后女性泌尿生殖综合征的特征:对外阴阴道萎缩诊断和治疗选择的意义。
Maturitas. 2015 Aug;81(4):462-9. doi: 10.1016/j.maturitas.2015.05.007. Epub 2015 May 30.
6
Shared decision-making on the use of hormone therapy: a nationwide survey in the Republic of Korea.激素疗法使用的共同决策:韩国的一项全国性调查。
Menopause. 2014 Jul;21(7):726-31. doi: 10.1097/GME.0000000000000170.
7
Cross-national study of women's use of hormone replacement therapy (HRT) in Europe.欧洲女性使用激素替代疗法(HRT)的跨国研究。
Int J Fertil Womens Med. 1997;42 Suppl 2:365-75.
8
The European Menopause Survey 2005: women's perceptions on the menopause and postmenopausal hormone therapy.2005年欧洲更年期调查:女性对更年期及绝经后激素治疗的看法
Gynecol Endocrinol. 2006 Jul;22(7):369-75. doi: 10.1080/09513590600842463.
9
[Attitudes to estrogen replacement therapy among Norwegian women].[挪威女性对雌激素替代疗法的态度]
Tidsskr Nor Laegeforen. 2006 Apr 27;126(9):1195-7.
10
Menopausal symptom management and prevention counseling after the Women's Health Initiative among women seen in an internal medicine practice.在内科诊所就诊的女性中,女性健康倡议之后的更年期症状管理与预防咨询。
J Womens Health (Larchmt). 2005 Jul-Aug;14(6):507-14. doi: 10.1089/jwh.2005.14.507.

引用本文的文献

1
Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: A Phase 3 Randomized Clinical Trial.依林扎奈坦治疗绝经相关血管舒缩症状:一项3期随机临床试验
JAMA Intern Med. 2025 Sep 8. doi: 10.1001/jamainternmed.2025.4421.
2
The Effect of Group Spiritual Reminiscence on the Sleep Quality of Postmenopausal Women in Iran: A Clinical Trial Study.团体精神回忆对伊朗绝经后女性睡眠质量的影响:一项临床试验研究。
J Relig Health. 2025 Sep 4. doi: 10.1007/s10943-025-02432-1.
3
Exit Interviews Examining Changes to Mood and Work/Productivity Impacts Related to Vasomotor Symptoms: Perspectives of Postmenopausal Women Receiving Elinzanetant in Phase III Clinical Trials.

本文引用的文献

1
The North American Menopause Society Statement on Continuing Use of Systemic Hormone Therapy After Age 65.北美更年期协会关于65岁后继续使用全身激素疗法的声明。
Menopause. 2015 Jul;22(7):693. doi: 10.1097/GME.0000000000000492.
2
The need to do better - Are we still letting our patients down and at what cost?追求更好的必要性——我们是否仍在辜负我们的患者,代价是什么?
Post Reprod Health. 2015 Jun;21(2):56-62. doi: 10.1177/2053369115586122. Epub 2015 May 11.
3
Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years.
离职访谈:探讨血管舒缩症状相关情绪变化及对工作/生产力的影响——来自接受艾林扎坦的绝经后女性在III期临床试验中的观点
Patient. 2025 Jul 12. doi: 10.1007/s40271-025-00748-4.
4
Qualitative exploration of women's experiences of vasomotor symptoms to support the content validity of patient-reported outcomes.对女性血管舒缩症状体验的质性探索,以支持患者报告结局的内容效度。
J Patient Rep Outcomes. 2025 Jul 1;9(1):79. doi: 10.1186/s41687-025-00914-0.
5
Psychometric evaluation of the HFDD, PROMIS SD SF 8b, and MENQOL questionnaire in women experiencing vasomotor symptoms associated with menopause.对经历绝经相关血管舒缩症状的女性进行高频数字判别测验(HFDD)、患者报告结果测量信息系统简版身体功能8b量表(PROMIS SD SF 8b)和更年期症状问卷(MENQOL)的心理测量学评估。
J Patient Rep Outcomes. 2025 May 7;9(1):50. doi: 10.1186/s41687-025-00875-4.
6
Prevalence and impact of vasomotor symptoms associated with menopause among Nordic women: Subgroup analysis from an international cross-sectional survey.北欧女性中与更年期相关的血管舒缩症状的患病率及影响:一项国际横断面调查的亚组分析
Acta Obstet Gynecol Scand. 2025 May 1. doi: 10.1111/aogs.15139.
7
Treatment satisfaction, unmet needs, and new treatment expectations for vasomotor symptoms due to menopause: women's and physicians' opinions.治疗满意度、未满足需求以及绝经相关血管舒缩症状的新治疗期望:女性和医生的观点。
Menopause. 2024 Sep 1;31(9):769-780. doi: 10.1097/GME.0000000000002399.
8
Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: OASIS 1 and 2 Randomized Clinical Trials.依林扎奈坦治疗绝经相关血管舒缩症状:OASIS 1和2随机临床试验
JAMA. 2024 Aug 22;332(16):1343-54. doi: 10.1001/jama.2024.14618.
9
Translation and validation of menopause quick 6 (MQ6) into the Malay language.将绝经快速 6 问卷(MQ6)翻译成马来语并进行验证。
BMC Prim Care. 2024 Mar 22;25(1):95. doi: 10.1186/s12875-024-02342-3.
10
Experience and severity of menopause symptoms and effects on health-seeking behaviours: a cross-sectional online survey of community dwelling adults in the United Kingdom.绝经症状的体验和严重程度及其对健康寻求行为的影响:英国社区居住成年人的横断面在线调查。
BMC Womens Health. 2023 Jul 14;23(1):373. doi: 10.1186/s12905-023-02506-w.
对于60到65岁的女性来说,中度至重度的血管舒缩症状和性症状仍然是个问题。
Menopause. 2015 Jul;22(7):694-701. doi: 10.1097/GME.0000000000000383.
4
Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women.复方生物同源激素疗法:识别美国女性的使用趋势和知识差距。
Menopause. 2015 Sep;22(9):926-36. doi: 10.1097/GME.0000000000000420.
5
Duration of menopausal vasomotor symptoms over the menopause transition.绝经过渡期间绝经血管舒缩症状的持续时间。
JAMA Intern Med. 2015 Apr;175(4):531-9. doi: 10.1001/jamainternmed.2014.8063.
6
Italy: health system review.意大利:卫生系统综述。
Health Syst Transit. 2014;16(4):1-168.
7
Trends of postmenopausal estrogen plus progestin prevalence in the United States between 1970 and 2010.1970年至2010年间美国绝经后雌激素加孕激素的使用流行趋势。
Obstet Gynecol. 2014 Oct;124(4):727-733. doi: 10.1097/AOG.0000000000000469.
8
Menopausal hormone therapy use in 17 European countries during the last decade.过去十年间17个欧洲国家更年期激素疗法的使用情况。
Maturitas. 2014 Nov;79(3):287-91. doi: 10.1016/j.maturitas.2014.07.002. Epub 2014 Aug 4.
9
The use of complementary and alternative medicine by women transitioning through menopause in Germany: results of a survey of women aged 45-60 years.德国处于更年期过渡阶段的女性对补充替代医学的使用:对 45-60 岁女性的调查结果。
Complement Ther Med. 2014 Feb;22(1):94-8. doi: 10.1016/j.ctim.2013.12.004. Epub 2013 Dec 11.
10
Risk of long-term hot flashes after natural menopause: evidence from the Penn Ovarian Aging Study cohort.自然绝经后长期潮热的风险:来自宾夕法尼亚卵巢衰老研究队列的证据。
Menopause. 2014 Sep;21(9):924-32. doi: 10.1097/GME.0000000000000196.